Disc Medicine IRON Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's foreign currency translation gains (losses)?
- Disc Medicine (IRON) reported foreign currency translation gains (losses) of -$10K in Q1 2026.
- How has Disc Medicine's foreign currency translation gains (losses) changed year-over-year?
- Disc Medicine's foreign currency translation gains (losses) decreased by 171.4% year-over-year, from $14K to -$10K.
- What does foreign currency translation gains (losses) mean?
- This metric represents the net gains or losses resulting from the translation of financial statements of foreign subsidiaries into the reporting currency. It reflects the impact of exchange rate fluctuations on the value of international assets and liabilities. Monitoring this helps investors understand the company's exposure to currency volatility in its global operations.